top of page

Discontinuation: Duolin nebuliser soln, New brand: Combiprasal nebuliser soln.

  • 2 hours ago
  • 1 min read

We are writing to inform you of the:


Discontinuation: Duolin nebuliser soln, salbutamol 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule


New listing: Combiprasal nebuliser soln, salbutamol 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule


Duolin nebuliser soln has been discontinued. The alternate Cipla brand has an expiry date of 30 June 2026.


A second alternate, Combiprasal brand will be funded from 1 May 2026.


  • Combiprasal active ingredients and strength remain the same as Duolin.

  • Combiprasal brand is not a Medsafe approved product and will need to be prescribed and dispensed in line with Section 29A of the Medicines Act

  • Section 29A of the Act requires the patient to be known at the time of supply. On this basis, supply on a Practitioner’s Supply Order is not possible. However, there are exceptional circumstances for some emergency medicines, when holding an emergency supply in stock may be essential for patient safety. Medsafe website PSO information.

  • A webpage with a downloadable patient leaflet is available to help reassure patients about this brand change Duolin nebules on Pharmac website

 

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

 

Please share this information:

Please share this information with your colleagues and within your networks.

 

If you no longer wish to receive emails from the Pharmac Implementation Team, please send a reply email with UNSUBSCRIBE in the subject heading. Thank you.

 

Ngā mihi,

 

Implementation Team

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz



bottom of page